ArticleNeuroImage2015
Accelerated vs. unaccelerated serial MRI based TBM-SyN measurements for clinical trials in Alzheimer's disease.
Article in NeuroImage, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
33 citing papers in PubMed, 46 citations in OpenAlex.
- Tau PET overlap index correlation with neuropathological findings.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026Article
- Reliability assessment of accelerated MR sequences for the estimation of structural and vascular markers in dementia.Scientific reports · 2025Article
- Implementation and validation of face de-identification (de-facing) in ADNI4.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2024Article
- Growth-Associated Protein 43 and Tensor-Based Morphometry Indices in Mild Cognitive Impairment.Neuroinformatics · 2024Article
- Reproducibility evaluation of the effects of MRI defacing on brain segmentation.Journal of medical imaging (Bellingham, Wash.) · 2023Article
- Longitudinal rates of atrophy and tau accumulation differ between the visual and language variants of atypical Alzheimer's disease.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2023Article
- Features of Idiopathic Intracranial Hypertension on MRI With MR Elastography: Prospective Comparison With Control Individuals and Assessment of Postintervention Changes.AJR. American journal of roentgenology · 2022Article
- Functional connectivity to the premotor cortex maps onto longitudinal brain neurodegeneration in progressive apraxia of speech.Neurobiology of aging · 2022Article
- The Overlap Index as a Means of Evaluating Early Tau PET Signal Reliability.Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2022Article
- Early diagnosis of Alzheimer's disease using machine learning: a multi-diagnostic, generalizable approach.Alzheimer's research & therapy · 2022Article
- Longitudinal Tau Positron Emission Tomography in Dementia with Lewy Bodies.Movement disorders : official journal of the Movement Disorder Society · 2022Article
- A computational model of neurodegeneration in Alzheimer's disease.Nature communications · 2022Article
- Impact of defacing on automated brain atrophy estimation.Insights into imaging · 2022Article
- Longitudinal atrophy in prodromal dementia with Lewy bodies points to cholinergic degeneration.Brain communications · 2022Article
- The Longitudinal Early-onset Alzheimer's Disease Study (LEADS): Framework and methodology.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2021Article
- Changes in Ventricular and Cortical Volumes following Shunt Placement in Patients with Idiopathic Normal Pressure Hydrocephalus.AJNR. American journal of neuroradiology · 2021Article
- DeepAtrophy: Teaching a neural network to detect progressive changes in longitudinal MRI of the hippocampal region in Alzheimer's disease.NeuroImage · 2021Article
- Selecting software pipelines for change in flortaucipir SUVR: Balancing repeatability and group separation.NeuroImage · 2021Article
- Changing the face of neuroimaging research: Comparing a new MRI de-facing technique with popular alternatives.NeuroImage · 2021Article
- The Use, Standardization, and Interpretation of Brain Imaging Data in Clinical Trials of Neurodegenerative Disorders.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2021Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
17 authors at 5 institutions in 2 countries.
Funding
Abstract
objectiveOur primary objective was to compare the performance of unaccelerated vs. accelerated structural MRI for measuring disease progression using serial scans in Alzheimer's disease (AD).
methodsWe identified cognitively normal (CN), early mild cognitive impairment (EMCI), late mild cognitive impairment (LMCI) and AD subjects from all available Alzheimer's Disease Neuroimaging Initiative (ADNI) subjects with usable pairs of accelerated and unaccelerated scans. There were a total of 696 subjects with baseline and 3 month scans, 628 subjects with baseline and 6 month scans and 464 subjects with baseline and 12 month scans available. We employed the Symmetric Diffeomorphic Image Normalization method (SyN) for normalization of the serial scans to obtain tensor based morphometry (TBM) maps which indicate the structural changes between pairs of scans. We computed a TBM-SyN summary score of annualized structural changes over 31 regions of interest (ROIs) that are characteristically affected in AD. TBM-SyN scores were computed using accelerated and unaccelerated scan pairs and compared in terms of agreement, group-wise discrimination, and sample size estimates for a hypothetical therapeutic trial.
resultsWe observed a number of systematic differences between TBM-SyN scores computed from accelerated and unaccelerated pairs of scans. TBM-SyN scores computed from accelerated scans tended to have overall higher estimated values than those from unaccelerated scans. However, the performance of accelerated scans was comparable to unaccelerated scans in terms of discrimination between clinical groups and sample sizes required in each clinical group for a therapeutic trial. We also found that the quality of both accelerated vs. unaccelerated scans were similar.
conclusionsAccelerated scanning protocols reduce scan time considerably. Their group-wise discrimination and sample size estimates were comparable to those obtained with unaccelerated scans. The two protocols did not produce interchangeable TBM-SyN estimates, so it is arguably important to use either accelerated pairs of scans or unaccelerated pairs of scans throughout the study duration.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.